FENNEC PHARMACEUTICALS INC.

(FENC)
  Bericht
Verzögert Nasdaq  -  27/05 21:59:54
5.820 USD   +0.69%
12.05.FENNEC PHARMACEUTICALS INC. : Wedbush behält seine Kaufempfehlung bei
MM
12.05.FENNEC PHARMACEUTICALS INC. : Wedbush bekräftigt seine Kaufempfehlung
MM
12.05.Fennec Pharmaceuticals verringert Nettoverlust in Q1
MT
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über FENNEC PHARMACEUTICALS INC.
23.05.Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
23.05.Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
12.05.FENNEC PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Conditio..
12.05.Fennec Pharmaceuticals Q1 Net Loss Narrows
12.05.Fennec Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Busi..
12.05.Fennec Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March ..
28.04.Fennec pharmaceuticals announces fda acceptance for filing of new drug application resu..
27.04.Wedbush on Fennec Pharmaceuticals' Pedmark NDA Resubmission
27.04.Fennec Pharmaceuticals Up 6% After Announcing FDA Acceptance for Filing of New Drug App..
27.04.Fennec Pharmaceuticals Announces FDA Acceptance for Filing of New Drug Application Res..
27.04.FENNEC PHARMACEUTICALS BRIEF : Announces FDA Acceptance for Filing of New Drug Application..
27.04.Fennec Pharmaceuticals Inc. Announces U.S. Food and Drug Administration Acceptance of N..
27.04.Fennec Pharmaceuticals Announces FDA Acceptance for Filing of New Drug Application Resu..
27.04.FENNEC PHARMACEUTICALS : FDA Accepts Pedmark Application's Resubmission
28.03.Fennec pharmaceuticals to participate in the 2022 maxim virtual growth conference
25.03.Fennec Pharmaceuticals to Participate in the 2022 Maxim Virtual Growth Conference
24.03.Wedbush Commentary on Fennec Pharmaceutics' Resubmission of Pedmark NDA
24.03.FENNEC PHARMACEUTICALS : RESUBMITS NEW DRUG APPLICATION TO U.S. FOOD AND DRUG ADMINSTRATIO..
24.03.FENNEC PHARMACEUTICALS INC. : Other Events, Financial Statements and Exhibits (form 8-K)
24.03.Fennec Pharmaceuticals Resubmits New Drug Application to U.S. Food and Drug Administrat..
24.03.Fennec Pharmaceuticals Files Again for FDA OK of Pedmark
24.03.Fennec Pharmaceuticals Resubmits New Drug Application for Pedmark
24.03.FENNEC PHARMACEUTICALS BRIEF : Resubmits New Drug Application to U.S. Food and Drug Admini..
24.03.Fennec Pharmaceuticals Resubmits New Drug Application to U.S. Food and Drug Administrat..
24.03.Fennec Pharmaceuticals Resubmits New Drug Application to U.S. Food and Drug Administrat..
28.02.FENNEC PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Conditio..
28.02.Fennec Pharmaceuticals Reports Net losses for Q4 of US$4.4 million
28.02.FENNEC PHARMACEUTICALS BRIEF : Adds Company has Approximately US$21.1 Million in Cash and ..
28.02.FENNEC PHARMACEUTICALS BRIEF : Says Resubmission of NDA for PEDMARK Targeted for the First..
28.02.FENNEC PHARMACEUTICALS BRIEF : Reports Net losses for Q4 of US$4.4 million ($0.18 per shar..
28.02.Fennec Pharmaceuticals Announces Fiscal Year 2021 Financial Results And Provides Busine..
28.02.Fennec Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 3..
31.01.FENNEC PHARMACEUTICALS : ANNOUNCES MANAGEMENT CHANGE - Form 8-K
31.01.FENNEC PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement, Financial Statem..
31.01.FENNEC PHARMACEUTICALS INC. : Change in Directors or Principal Officers, Financial Stateme..
31.01.Fennec Pharmaceuticals Chief Commercial Officer Resigns
31.01.Fennec Pharmaceuticals Announces Management Change
31.01.Shubh Goel to Depart Fennec Pharmaceuticals Inc. as Chief Commercial Officer in Late Fe..
17.01.FENNEC PHARMACEUTICALS : Corporate Presentation January 2022
2021FENNEC PHARMACEUTICALS : Receives Complete Response Letter from the FDA for its New Drug A..
2021Fennec Pharmaceuticals Down 4% in US Pre-Market, Receives Complete Response Letter From..
2021Fennec Gets Official Notice of FDA Rejection of Pedmark
2021FENNEC PHARMACEUTICALS BRIEF : Receives Complete Response Letter from the FDA for its New ..
2021Fennec Pharmaceuticals Receives Complete Response Letter from the FDA for its New Drug ..
2021Fennec pharmaceuticals expects to receive complete response letter from the fda for its..
2021Back to the guessing game
2021Fennec Plunges 48% to Fresh 52-Week Low, as FDA Indicates "Deficiencies" in Manufacture..
2021FENNEC PHARMACEUTICALS : Expects to Receive Complete Response Letter from the FDA for its ..
2021FENNEC PHARMACEUTICALS INC. : Other Events, Financial Statements and Exhibits (form 8-K)
2021Fennec Shares Plunge as Pedmark Appears Headed for FDA Rejection
2021Wall Street Set for Rebound After Omicron-Induced Slump
2021Top Premarket Decliners
2021Fennec Plunges 45% in Pre-Market Trade, as FDA Indicates "Deficiencies" in Manufacturer..
2021Fennec Says It Expects to Receive FDA's Complete Response Letter for Pedmark New Drug A..
2021Fennec does not expect U.S. approval for hearing loss drug, shares slump
2021Fennec Pharmaceuticals Expects FDA to Reject Pedmark Application Again
2021Fennec expects U.S. FDA to decline application for hearing loss drug
2021Fennec Pharmaceuticals Expects to Receive Complete Response Letter from the FDA for its..
2021Fennec Pharmaceuticals Inc. Expects to Receive Complete Response Letter from the FDA fo..
2021FENNEC PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Conditio..
2021Fennec Pharmaceuticals Announces Third Quarter 2021 Financial Results, Provides Busines..
2021Fennec Pharmaceuticals Q3 Net Loss Narrows, Revenue Stays Null
2021Fennec Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Busi..
2021Fennec Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Busi..
2021Fennec Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter Ended Septem..
2021FENNEC PHARMACEUTICALS : to Participate in Upcoming Investor Conferences
2021FENNEC PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and R..
2021FENNEC PHARMACEUTICALS : Reports Q2 Net loss of US$0.15 Per Share; Provides Business Updat..
2021FENNEC PHARMACEUTICALS : Earnings Flash (FRX.TO) FENNEC PHARMACEUTICALS Posts Net loss for..
2021FENNEC PHARMACEUTICALS : Earnings Flash (FRX.TO) FENNEC PHARMACEUTICALS Posts Net loss for..
2021Fennec Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Bus..
2021NORTH AMERICAN MORNING BRIEFING : Stock Futures -2-
2021FENNEC PHARMACEUTICALS INC. : Submission of Matters to a Vote of Security Holders (form 8-..
2021Fennec Announces Results of Annual Meeting
2021FENNEC PHARMACEUTICALS : ANNOUNCES AMENDMENT TO INCREASE EXISTING SENIOR DEBT FACILITY (Fo..
1  2  3Weiter
Anstehende Termine für FENNEC PHARMACEUTICALS INC.